Copyright
©The Author(s) 2003.
World J Gastroenterol. Aug 15, 2003; 9(8): 1697-1701
Published online Aug 15, 2003. doi: 10.3748/wjg.v9.i8.1697
Published online Aug 15, 2003. doi: 10.3748/wjg.v9.i8.1697
Table 1 Clinical features and therapeutic modalities in two groups
| TACE group cases (%) | TACE plus irradiation group cases (%) | P value | ||
| Sex | Male | 75 (84.3) | 68 (89.5) | |
| Female | 14 (15.7) | 8 (10.5) | 0.327 | |
| Age | < 60 years | 66 (74.2) | 57 (75.0) | |
| ≥ 60 years | 23 (25.8) | 19 (25.0) | 0.901 | |
| AFP | < 400 ng/ml | 45 (50.6) | 42 (55.3) | |
| ≥ 400 ng/ml | 44 (49.4) | 34 (44.7) | 0.547 | |
| No. of lesions | Solitary | 59 (66.3) | 51 (67.1) | |
| Multiple | 30 (33.7) | 25 (32.9) | 0.912 | |
| Tumor | 1 lobe | 72 (81.9) | 52 (68.4) | |
| extensiona | 2 lobe | 17 (19.1) | 24 (31.6) | 0.064 |
| Tumor size | 5-10 cm | 51 (57.3) | 47 (61.8) | |
| > 10 cm | 38 (42.7) | 29 (38.2) | 0.554 | |
| Portal | Absent | 67 (75.3) | 62 (81.6) | |
| thrombosis | Present | 22 (24.7) | 14 (18.4) | 0.329 |
| Child grade | A | 74 (83.2) | 63 (82.9) | |
| B | 15 (16.8) | 13 (17.1) | 0.996 | |
| Okuda stage | I | 24 (27.0) | 29 (38.2) | |
| II | 65 (73.0) | 46 (60.5) | ||
| III | 1 (1.3) | 0.155 | ||
| TACE times | 1 | 27 (30.3) | 27 (35.5) | |
| 2 | 42 (47.2) | 28 (36.8) | ||
| 3 | 15 (16.9) | 11 (14.5) | ||
| 4 | 5 (5.6) | 10 (13.2) | 0.253 | |
| Spongostan use | No | 48 (53.9) | 44 (57.9) | |
| Yes | 41 (46.1) | 32 (42.1) | 0.610 |
- Citation: Guo WJ, Yu EX, Liu LM, Li J, Chen Z, Lin JH, Meng ZQ, Feng Y. Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma. World J Gastroenterol 2003; 9(8): 1697-1701
- URL: https://www.wjgnet.com/1007-9327/full/v9/i8/1697.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i8.1697